Biography
Dr. Hadjipanayis is a Professor of Neurosurgery and Oncological Sciences at the Icahn School of Medicine at Mount Sinai. He serves as Chair of Neurosurgery at Mount Sinai Beth Israel and Director of Neurosurgical Oncology for the Mount Sinai Health System. He has devoted his entire career to the treatment of brain tumor patients and is Director of the Mount Sinai Brain Tumor Nanotechnology Laboratory in the Tisch Cancer Institute. He helped lead the effort for FDA approval of 5-ALA (Gleolan) in the US for use during glioma surgery in June 2017.
